Terms: = Brain cancer AND PCSK7, Q16549, 9159, ENSG00000160613, PC8, SPC7, PC7, LPC
8 results:
1. Assessment of the cut-off value of quantitative liver-portal vein contrast ratio in the hepatobiliary phase of liver MRI.
Takatsu Y; Nakamura M; Shiozaki T; Narukami S; Yoshimaru D; Miyati T; Kobayashi S
Clin Radiol; 2021 Jul; 76(7):551.e17-551.e24. PubMed ID: 33902888
[TBL] [Abstract] [Full Text] [Related]
2. Microglial dysfunction as a key pathological change in adrenomyeloneuropathy.
Gong Y; Sasidharan N; Laheji F; Frosch M; Musolino P; Tanzi R; Kim DY; Biffi A; El Khoury J; Eichler F
Ann Neurol; 2017 Nov; 82(5):813-827. PubMed ID: 29059709
[TBL] [Abstract] [Full Text] [Related]
3. brain tumor-targeted therapy by systemic delivery of siRNA with Transferrin receptor-mediated core-shell nanoparticles.
Wei L; Guo XY; Yang T; Yu MZ; Chen DW; Wang JC
Int J Pharm; 2016 Aug; 510(1):394-405. PubMed ID: 27374198
[TBL] [Abstract] [Full Text] [Related]
4. DNA-binding and cytotoxic efficacy studies of organorhenium pentylcarbonate compounds.
Medley J; Payne G; Banerjee HN; Giri D; Winstead A; Wachira JM; Krause JA; Shaw R; Pramanik SK; Mandal SK
Mol Cell Biochem; 2015 Jan; 398(1-2):21-30. PubMed ID: 25262122
[TBL] [Abstract] [Full Text] [Related]
5. The potential application of a transcriptionally regulated oncolytic herpes simplex virus for human cancer therapy.
Miao L; Fraefel C; Sia KC; Newman JP; Mohamed-Bashir SA; Ng WH; Lam PY
Br J Cancer; 2014 Jan; 110(1):94-106. PubMed ID: 24196790
[TBL] [Abstract] [Full Text] [Related]
6. The proprotein convertases are potential targets in the treatment of dyslipidemia.
Seidah NG; Prat A
J Mol Med (Berl); 2007 Jul; 85(7):685-96. PubMed ID: 17351764
[TBL] [Abstract] [Full Text] [Related]
7. Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid.
Kishi Y; Okudaira S; Tanaka M; Hama K; Shida D; Kitayama J; Yamori T; Aoki J; Fujimaki T; Arai H
J Biol Chem; 2006 Jun; 281(25):17492-17500. PubMed ID: 16627485
[TBL] [Abstract] [Full Text] [Related]
8. 31P NMR phospholipid characterization of intracranial tumors.
Merchant TE; van der Ven LT; Minsky BD; Diamantis PM; Delapaz R; Galicich J; Glonek T
Brain Res; 1994 Jun; 649(1-2):1-6. PubMed ID: 7953620
[TBL] [Abstract] [Full Text] [Related]
